Adverse effects of proton pump inhibitors.
Proton pump inhibitors (PPI) are very effective drugs used largely in acid related disorders. During the last years concern have been raised regarding their overutilisation in benign condition, such as gastroesophageal reflux disease. The debate focussed also on the risk of adverse events related to long term use of PPI. Apart of the case of Helicobacter Pylori (H. Pylori) positive patients, in whose long term acid suppression lead to the development of corpus predominant atrophic gastritis, precursor of cancer; the other assumed adverse events, have never been demonstrated in prospective studies. The attention should move towards the appropriate prescription of PPI, rather than the fear adverse effects of PPI. In fact, in clinical practise, PPI are often prescribed in patients without a specific acid related disease and continued long term based on their safety profile. This review focus on the main adverse events related to long term PPI use.
Lodato
Francesca
F
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy. francesca.lodato@unibo.it
Azzaroli
Francesco
F
Turco
Laura
L
Mazzella
Natalia
N
Buonfiglioli
Federica
F
Zoli
Marco
M
Mazzella
Giuseppe
G
D050723:Fractures, Bone / Q000139:chemically induced; D005759:Gastroenteritis / Q000139:chemically induced / Q000382:microbiology; D006801:Humans; D008275:Magnesium Deficiency / Q000139:chemically induced; D011127:Polyps / Q000139:chemically induced; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000139:chemically induced; D014806:Vitamin B 12 Deficiency / Q000139:chemically induced
D054328:Proton Pump Inhibitors